Table 1.
Clinical characteristics of Study Patients.
| Total (n = 21) | |
|---|---|
| Male sex (%) | 14 (67) |
| Age (y) | 63 (7) |
| LVEF (%) | 58 (4) |
| Left ventricular dysfunction (LVEF<50%) (n) | 3 (14) |
| LVEDD (mm) | 51 (5) |
| IVS (mm) | 11 (3) |
| LA diameter (mm) | 44 (4) |
| Structural Cardiomyopathy (n) | 6 (28) |
| Coronary Artery Disease (n) | 2 (9) |
| Hypertension (n) | 13 (62) |
| Mitral Regurgitation | mild: 1 (5) |
| moderate: 2 (9) | |
| History of Cerebral Ischemic Event (n) | 3 (14) |
| Antiarrhythmic therapy (n) | Amiodarone: 8 (38) |
| Dronedarone: 1 (5) | |
| Sotalol: 1 (5) | |
| Flecainide: 3 (14) |
Values are given as n (%) or mean with standard deviation.
LA, left atrium; IVS, interventricular septum; LVEDD, left ventricular end-diastolic diameter; LVEF, left ventricular ejection franction.